Faculty and fellows in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center have made outstanding contributions to understanding allergic and pulmonary disease and critical care, from the most cellular mechanisms to population science. Our specialty research groups have made major contributions to their respective fields.
Our research success is demonstrated through:
Election of many faculty to national societies such as the American Society of Clinical Investigation and the Association of American Physicians
Faculty members’ service as leaders in international organizations such as the American Thoracic Society, the American Academy of Allergy, Asthma and Immunology, and the Society of Critical Care Medicine
An impressive record of NIH funding for faculty investigators within the division, and publications at the highest level
Awards for fellows and junior faculty recognizing their accomplishments through the American Thoracic Society, the American Academy of Allergy, Asthma, and Immunology, and the Society of Critical Care Medicine. Each of them has had success in competitive career development awards from the NIH and other organizations.
The Division of Allergy, Pulmonary and Critical Care Medicine also offers two T32 research-focused training programs.
See below to learn more about our specific areas of research: asthma and allergy, critical care, interstitial lung disease, interventional pulmonology, lung transplantation and pulmonary hypertension.
Discoveries that advance human health
Wes Ely, MD, with the Division of Allergy, Pulmonary and Critical Care Medicine at VUMC, along with his team, designed a clinical trial that found that Baricitinib reduces death in patients with severe COVID-19.
Asthma and Allergy
Multi-disciplinary, highly collaborative research programs in clinical, translational and basic science research in asthma and allergic diseases.
Critical Care
Robust programs in basic mechanisms of acute lung injury, sepsis, ICU delirium, brain injury, lung transplantation and recovery in critical care settings.
Interstitial Lung Disease
We focus on understanding disease mechanisms that lead to Interstitial Lung Disease to improve ability to detect ILD at early stages and develop new treatments.
Interventional Pulmonology
This program involves investigator-initiated and industry-sponsored clinical trials, biomedical engineering research, lung cancer biomarker research and more.
Lung Transplantation
Basic, translational, and clinical research to improve the care of lung transplant recipients and to optimize utilization of donor lungs.
Pulmonary Hypertension
Our main focus is understanding the rare disease, pulmonary arterial hypertension (PAH) with a focus on idiopathic and heritable forms of this disease.
Research Centers and Labs
Division faculty members lead a number of research centers and labs across the VUMC campus.
Clinical Trials
Learn more about clinical trials conducted within the Division of Allergy, Pulmonary, and Critical Care Medicine.
Publications
Read recent publications on the latest research by division faculty.